Skin moisturation for youthfull freshness
- superficial wrinkles
- face
- neck
- decollete
- back of hands
|
Concentration Hayluronic acid content |
12.8 mg/ml not cross linked hyaluronic acid |
| Indications | Superficial wrinkles: face, neck, decollete, back of hands |
| Estimated duration | 3 months |
| Needle size |
30G |
| Packaging | 2 x 1.0 ml |
| Skin level | superficial dermis |
| Injection technique | Serial puncture technique, Retrograde linear threading technique, Fan technique |
| Storage | between +2oC and +25oC |
| Shelf life | 2 years |
Wrinkle treatment for first signs of wrinkles
- superficial to medium wrinkles
- perioral lines
- general touch up
|
Concentration Hayluronic acid content |
6 mg/ml high cross linked hyaluronic acid |
| Indications | superficial to medium wrinkles, perioral lines, general touch up |
| Estimated duration | 3-6 months |
| Needle size |
30G |
| Packaging | 2 x 1.0 ml |
| Skin level | superficial to middle dermis |
| Injection technique | Retro tracing, serial points, Fan techniques or combination of all |
| Storage | between +2oC and +25oC |
| Shelf life | 2 years |
Lip augmentation and lip contouring
- medium wrinkles
- lip augmentation
- lip contour
|
Concentration Hayluronic acid content |
12.8 mg/ml high cross linked hyaluronic acid |
| Indications | medium wrinkles especially lip augmentation and lip contour |
| Estimated duration | 6-12 months |
| Needle size |
27G |
| Packaging | 1 x 1.0 ml |
| Skin level | middle dermis to deep dermis |
| Injection technique | Retro tracing, serial points, Fan techniques or combination of all |
| Storage | between +2oC and +25oC |
| Shelf life | 2 years |
Wrinkle treatment for medium folds
- medium wrinkles
- lip contour
|
Concentration Hayluronic acid content |
12 mg/ml high cross linked hyaluronic acid |
| Indications | medium wrinkles and lip contouring |
| Estimated duration | 6-12 months |
| Needle size |
27G |
| Packaging | 2 x 1.0 ml |
| Skin level | middle dermis to deep dermis |
| Injection technique | linear retrotracing, multiple point and fan technique or combination of all |
| Storage | between +2oC and +25oC |
| Shelf life | 2 years |
Volume creation
- deep folds
- volume creation in the face
|
Concentration Hayluronic acid content |
18 mg/ml high cross linked hyaluronic acid |
| Indications | deep wrinkles contour of the face and volume creation |
| Estimated duration | 12-14 months |
| Needle size |
27G |
| Packaging | 2 x 1.0 ml |
| Skin level | deep dermis / hypodermis |
| Injection technique | Retro tracing, serial points, Fan techniques or combination of all |
| Storage | between +2oC and +25oC |
| Shelf life | 2 years |
Optimal volume - higher lifting effect with less quantity
- very deep folds
- optimal volume creation
- ideal for nasal dorsum
|
Concentration Hayluronic acid content |
27 mg/ml high cross linked hyaluronic acid |
| Indications | very deep wrinkles especially contour of the face and volume creation |
| Estimated duration | 14-18 months |
| Needle size |
27G |
| Packaging | 2 x 1.0 ml |
| Skin level | hypodermis andepiperiostal |
| Injection technique | Retro tracing, serial points, Fan technique or combination of all |
| Storage | between +2oC and +25oC |
| Shelf life | 2 years |
Lip Contouring and Lip Augmentation
- re-defines lip contours
- lip augmentation
- improve the natural and proportional shape of your lips
- ideal for spreading and molding the lips
- exceptionally good for tear through
| Total HA concentration |
12 mg/ml |
| Lidocaine concentration | 0.3% |
| Crosslinking agent | BDDE |
| Volum/Packaging |
1 x 1.0 ml |
| Needle size | 27G |
| Estimated duration | 6-9 months |
| Volumising effect | ooo |
| Depth of injection | lips muscle and contour line |
| Purpose | Wrinkle treatment |
Fills and smoothes medium sized wrinkles
- middle to deep dermis injection
- correction of moderate facial wrinkles and folds
- lip augmentation and lip contours
| Total HA concentration |
16 mg/ml |
| Lidocaine concentration | 0.3% |
| Crosslinking agent | BDDE |
| Volum/Packaging |
1 x 1.0 ml |
| Needle size | 27G |
| Estimated duration | 6-9 months |
| Volumising effect | oooo |
| Depth of injection | middle to deep dermis |
| Purpose | Wrinkle treatment |
Correction of deep folds
- deep dermis injection
| Total HA concentration |
20 mg/ml |
| Lidocaine concentration | 0.3% |
| Crosslinking agent | BDDE |
| Volum/Packaging |
1 x 1.0 ml |
| Needle size | 27G |
| Estimated duration | 9-12 months |
| Volumising effect | ooooo |
| Depth of injection | deep dermis/ hypodermis |
| Purpose | Volumisation |
Facial contouring, volume and correction of deep folds
- for subcutaneous tissue
- lifting effect
| Total HA concentration |
24 mg/ml |
| Lidocaine concentration | 0.3% |
| Crosslinking agent | BDDE |
| Volum/Packaging |
1 x 1.0 ml |
| Needle size | 27G |
| Estimated duration | 12-14 months |
| Volumising effect | oooooo |
| Depth of injection | hypodermis/epiperiostal |
| Purpose | Volumisation |
NOVATOX is a high dosage anti-aging preparation made of hyaluronic acid with a comprehensive combination of active agents for reduction of symptoms of aging and to support all biological processes in the skin.
Visible wrinkle reducing effect without injection
- against dry skin folds, aging wrinkles and mimic folds
- Acetyl Hexapeptide-3 reduces mimic folds and leads to relaxation of the facial mimic areas
- Acmella Oleracea has an additional impact on mimical contractions.
- Phytoestrogenes are isolated from various plants (Soy, Redclover, Iris). They take over the part of carrier agents which stimulate fibroblasts for a biological production of Elastin, Collagen and Hyaluron.
- Tripeptide-1 is a biosynthetical produced Peptide which stimulates the production of Collagen III fibres. Collagen III structures Collagen I within the dermis. The dermis is tightened and lifted by Tripeptide-1.
- triple active preparation relaxes, hydrates, lifts the skin
- complemantary treatment to improve dermal filler effects
Almost every second woman develops cellulite during her lifetime.
This condition is caused by accumulations of engrossed fat cells at thighs, hips, belly and the backside. Predisposition, slackening of connective tissue caused by hormonal changes, the structure of fatty tissue as well as reduced blood- and lympf circulation influcence the development of cellulite.
NOVAFORM is an innovative, highly concentrated active agent which, regularily used, reduces the symptoms of cellulite.
NOVAFORM accelerates lipolysis (fat tissue destroying) through
- Chrysin, Coffeine and Bupleurum Extract improve splitting up fat tissue.
- Carnitin and CoEnzym A accelerate the degradation and transport of free fatty acids.
- Hyaluronic acid tightens and smoothes the skin surface and transports active agents into the deeper skin layers.
